| |||||||
|
NovAseptic Sampling Systems Eliminate the Risk of False Positives Sampling
to verify the acceptability of an aseptic pharmaceutical drug product has always
been a procedure of ultimate importance relating to any validatable production
process. NovAseptic
has developed a totally unique, pre-sterilized, disposable, and totally enclosed
sampling system that will assist in the elimination of false positives. By
incorporating the NovaSeptum you can eliminate the requirement to clean and
steam in place between samples. Furthermore,
you can be assured that your sample will not be compromised from point of sample
to point of analysis. The
NovaSeptum has been validated for use by many of the world’s leading
Pharmaceutical and Biotechnology Companies.
Recent
product enhancements have further increased the demand for the NovaSeptum, these
being the introduction of an autoclavable range for applications where mobile
production vessels are autoclaved whilst fully assembled, a new 2mm sample
needle designed for cell culture applications and suspensions, and the
introduction of a three piece sample retrieval assembly which provides complete
flexibility and security for the person responsible for sample analysis.
Additionally, new production techniques has resulted in a reduction in
the guaranteed endotoxin level from <20EU/device to <2.15 EU/device on all
NovaSeptum products. For
those currently using the NovaSeptum, the following inherent advantages are
being experienced:
For
further information email Neil Robinson, Managing Director, NovAseptic UK Ltd on
neil.robinson@novaseptic.co.uk
or visit the web site www.novaseptic.com
|
|
| ||||||||